Patient-Reported Outcomes, Cognitive Decline, and Costs of Autologous Stem Cell Transplant After Induction for Patients with Multiple Myeloma

Type of Cancer
Multiple Myeloma

Phase

Division (Location)

Study ID

NCT#

Brief Description
Patient-Reported Outcomes, Cognitive Decline, and Costs of Autologous Stem Cell Transplant After Induction for Patients with Multiple Myeloma

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.